Actively Recruiting
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
Led by Istituto Auxologico Italiano · Updated on 2025-05-07
200
Participants Needed
3
Research Sites
156 weeks
Total Duration
On this page
Sponsors
I
Istituto Auxologico Italiano
Lead Sponsor
A
A.O.U. Città della Salute e della Scienza
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to understand the clinical variability in a population of ALS patients using multidimensional biomarkers. The main questions it aims to answer are: * Which set of biomarkers explain genotypic-phenotypic correlations in ALS? * Which set of biomarkers can be used to subdivide the ALS population in homogeneous subgroups? Participants will undergo: * neurological evaluation * neurophysiological evaluation * neuropsychological evaluation * whole exome sequencing * biomarker measurement in CSF and plasma
CONDITIONS
Official Title
Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of ALS or other motor neuron disease
- Residence near the study centers
You will not qualify if you...
- Refusal to participate in the study
- Unable or unwilling to perform follow-up visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Ospedale San Raffaele
Milan, MI, Italy, 20132
Actively Recruiting
2
Ospedale San Luca
Milan, MI, Italy, 20149
Actively Recruiting
3
AOU Città della Salute e della Scienza
Torino, TO, Italy, 10126
Actively Recruiting
Research Team
N
Nicola Ticozzi, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here